FDA
-
-
-
-
-
-
-
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
-
-
-
-
-
-
-
Longeveron® Appoints Marie Washburn as Chief Financial Officer
-
-
-
-
-
-
-
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
-
-
-
-
-
-
-
Longeveron (LGVN) PT Lowered to $8 at H.C. Wainwright
-
-
-
-
-
-
-
Longeveron closes $15 million private placement with potential $15 million more
-
-
-
-
-
-
-
Longeveron® Appoints Stephen H. Willard as Chief Executive Officer
-
-
-
-
-
-
-
Longeveron receives patent for stem cell therapy treating female sexual dysfunction
-
330,323 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

